| Health / Medical Topics |
WT1-Sensitized Allogeneic T-Lymphocytes
A population of allogeneic T-cells sensitized with Wilms tumor 1 (WT1) antigen with potential immunostimulatory and antineoplastic activities. Upon administration, WT1-sensitized T cells may bind to and lyse WT1-expressing tumor cells. WT1 antigen, a zinc finger DNA-binding protein acting as a transcriptional activator or repressor depending on the cellular or chromosomal context, is overexpressed in leukemic cells and in a vast number of nonhematological solid tumors. (NCI Thesaurus)
YOU MAY ALSO LIKE
An anti-CD7 immunotoxin comprised of the monoclonal antibody WT1 and the ricin-a chain toxin, causing decreased T-lymphocyte production, natural killer cell activity,…
Human WT1-AS wild-type allele is located in the vicinity of 11p13 and is approximately 23 kb in length. This allele, which encodes…
This gene may play a role in the regulation of gene expression.
An immunotherapeutic consisting of the recombinant fusion protein WT1-A10 combined with the adjuvant ASO1B with potential immunostimulating and antineoplastic activities. Upon…
Human WT1 wild-type allele is located in the vicinity of 11p13 and is approximately 48 kb in length. This allele, which encodes…
A peptide cancer vaccine comprised of a peptide derived from Wilms tumor gene 1 (WT1) protein, with potential immunomodulating and antineoplastic…
